Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
114 hedge funds and large institutions have $268M invested in Surmodics in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 39 reducing their positions, and 14 closing their positions.
15% more capital invested
Capital invested by funds: $233M → $268M (+$35.4M)
10% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 39
7% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 14
1% more funds holding
Funds holding: 113 → 114 (+1)
39% less call options, than puts
Call options by funds: $321K | Put options by funds: $526K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$4.18M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.76M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$2.46M |
| 4 |
TA
Teton Advisors
Rye,
New York
|
+$1.58M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.67M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$2.79M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.2M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.21M |
| 5 |
Morgan Stanley
New York
|
-$923K |
SRDX Hedge Fund Activity: Q3 2013 in Review
114 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q3 2013, worth a combined $268M — up 15% from $233M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new SRDX positions and 14 closed out — a net gain of 1 holder — while 43 added to existing stakes and 39 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $4.18M. The largest seller was Fidelity Investments, exiting entirely with an estimated $9.67M sold.
- 114 institutional investors held Surmodics (SRDX) as of Q3 2013, up from 113 in Q2 2013.
- Funds reported $268M of Surmodics stock for Q3 2013, up 15% quarter-over-quarter.
- 15 funds opened new Surmodics positions in Q3 2013 and 14 closed out, a net change of +1 holder.
- The largest Surmodics buyer in Q3 2013 was JP Morgan Chase, an estimated $4.18M added.
- The largest Surmodics seller in Q3 2013 was Fidelity Investments, an estimated $9.67M sold.
Based on aggregated 13F filings for Q3 2013.